St. Jude's device used in stenting procedures gets FDA OK

10/23/2013 | (Boston)

St. Jude Medical has received premarket approval from the FDA for its Ilumien Optis system. The next-generation device uses a combination of optical coherence tomography and fractional flow reserve technology to allow surgeons to monitor blood flow and visualize the heart during stenting procedures.

View Full Article in: (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC